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ABSTRACT 
Introduction 
The associations between smoking prevalence, socioeconomic group and lung cancer 
outcomes are well established. There is currently limited evidence for how inequalities could 
be addressed through specific smoking cessation interventions (SCIs) for a lung cancer 
screening eligible population.  This systematic review aims to identify the behavioural 
elements of SCIs used in older adults from low socioeconomic groups, and to examine their 
impact on smoking abstinence and psychosocial variables. 
Method 
Systematic searches of Medline, EMBASE, PsychInfo and CINAHL up to November 2018 
were conducted. Included studies examined the characteristics of SCIs and their impact on 
relevant outcomes including smoking abstinence, quit motivation, nicotine dependence, 
perceived social influence and quit determination. Included studies were restricted to 
socioeconomically deprived older adults who are at (or approaching) eligibility for lung 
cancer screening. Narrative data synthesis was conducted.  
Results 
Eleven studies met the inclusion criteria. Methodological quality was variable, with most 
studies using self-reported smoking cessation and varying length of follow-up. There were 
limited data to identify the optimal form of behavioural SCI for the target population. Intense 
multimodal behavioural counselling that uses incentives and peer facilitators, delivered in a 
community setting and tailored to individual needs indicated a positive impact on smoking 
outcomes. 
Conclusion  
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Tailored, multimodal behavioural interventions embedded in local communities could 
potentially support cessation among older, deprived smokers. Further high-quality research is 
needed to understand the effectiveness of SCIs in the context of lung screening for the target 
population. 
Keywords: Smoking, smoking cessation, older, deprived, lung cancer, lung cancer screening 
Article summary 
 There is a current gap in knowledge about the most suitable form of behavioural 
smoking cessation intervention (SCI) for older, deprived smokers who are most likely 
to be eligible for lung screening 
 This systematic review suggests that tailored, multimodal behavioural SCIs could 
support smoking cessation for those most likely to be eligible for lung screening; 
however, the studies included in the review were heterogeneous in design, SCI 
modality, sample size, intervention timing and measurement of smoking abstinence 
 There is a lack of rigorous, high quality research for the target population  
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INTRODUCTION 
Smoking is the leading global cause of death and disease (1) and data show that there are 
approximately 7.4 million adult cigarette smokers in the United Kingdom (2, 3). Twenty-six 
percent of smokers in the UK are aged 50 years or older (3); these individuals tend to have 
long standing smoking histories, are often from deprived communities and are a population 
that are likely to be eligible for future lung screening implementation.  The associations 
between smoking prevalence, socioeconomic group and a range of chronic disease outcomes, 
including lung cancer outcomes are well established, with higher smoking rates and greater 
lung cancer incidence and mortality (4-6) among people living in deprived areas.  
The US Preventive Services Task Force recommends annual low-dose computed tomography 
screening for those who are high-risk heavy smokers, including adults aged 55-80 years old, 
with a 30 pack-year history (7). LDCT lung cancer screening has the potential to prompt a 
smoking cessation attempt and evidence for integrated smoking cessation support is growing 
(8-11), with research demonstrating promising results for quit rates when using a combined 
approach of smoking cessation support in a lung screening setting (9).  
Prior to implementing appropriate smoking cessation intervention (SCIs) in a lung screening 
context in the UK, it is important to understand the factors that influence cessation attempts 
in older, deprived smokers who may be eligible for lung cancer screening. Known barriers to 
smoking cessation in this population include higher nicotine dependence, less motivation to 
quit, more life stress, lack of social support and differences in perceptions of smoking (12-
14). Smokers from a low socioeconomic background may find quitting more difficult due to 
lack of support from their family members or community with quit attempts (15), partly due 
to higher smoking prevalence and normalisation of smoking in their social networks (16). 
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Studies suggest that cessation attempts in older smokers are more likely to fail due to heavy 
nicotine dependence and insufficient motivating factors such as self-efficacy to quit (17, 18). 
Using pharmacotherapy with structured behavioural support to assist smoking cessation has 
shown promise with disadvantaged smokers (19, 20). Intensive SCIs involving tailored 
pharmacotherapy and behavioural counselling to increase self-efficacy are most effective for 
deprived smokers (21). However further research is needed to understand specific 
characteristics of behavioural SCIs, such as mode of delivery, setting, intensity and duration, 
that could be used for older, deprived smokers.  
A recent review by Iaccarino (22) attempted to identify the best approach for delivering SCIs 
in a lung cancer screening setting and concluded that the optimal strategy remains unclear. 
There is a need to identify gaps in the evidence surrounding the optimal models for integrated 
smoking cessation in a lung screening setting, focusing specifically on a disadvantaged lung 
screening eligible population, as well as gain a better understanding of what form of SCI may 
work best for this population in the UK.    
The aims of this systematic review were to identify the behavioural aspects of SCIs for older, 
deprived adults who are eligible (or approaching eligibility) for lung cancer screening, and to 
explore which elements of the interventions were most effective in reducing smoking 
abstinence and modifying psychosocial variables.  The findings from the systematic review 
will contribute to further understanding of optimal SCIs for individuals who are a target 
population for lung cancer screening. 
METHODS 
The systematic review was registered on PROSPERO (CRD42018088956) and followed the 
PRISMA guidelines (23). Throughout all stages of the search, data extraction and quality 
appraisal, 20% of studies were double-checked for consistency by another member of the 
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team (RP). All discrepancies were resolved through discussion. Data duplication was 
managed by removing duplications using a reference management software package 
(EndNote X9), which were then manually checked. 
Search strategy 
The literature was searched from 1990 to November 2018 on electronic databases: Medline, 
EMBASE, PsychInfo and CINAHL. Search terms related to smoking cessation, SCIs and 
socioeconomic status were used (Table 1). To limit restricting the search in relation to age, 
papers were manually screened to identify studies that used a relevant sample.  
Table 1: PICO tool 
PICO Description Search terms and connectors 
Population Individuals from socioeconomically 
deprived groups, defined through 
either individual or area level 
indicators  
(Depriv* or disadvantage* or inequit* 
or socioeconomic or socio-economic or 
sociodemographic or socio-
demographic or social class or 
deprivation group or poverty or low 
income or social welfare).tw. 
Intervention A range of interventions including 
individual and group counselling, self-
help materials, pharmacological 
interventions (e.g. nicotine 
replacement therapy), social and 
environmental support, comprehensive 
programmes and incentives 
Smoking Cessation/ and (intervention* 
or initiative* or strategy* or program* 
or scheme* or outcome* or approach*  
).tw. 
Comparison All study types with a pre/post 
intervention and/or a control group  
- 
 
Outcome Primary outcome: smoking abstinence 
Secondary outcome: Moderating 
variables (e.g. nicotine dependence, 
quit motivation, self-efficacy, social 
support and influences) 
((nicotine or tobacco or smok* or 
cigarette) adj (quit* or stop* or cess* or 
cease* or cut down or "giv* up" or 
reduc*  )).tw. 
 
Study eligibility criteria  
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All searches were restricted to high-income countries (24). Inclusion criteria for the included 
publications were; 'Socioeconomically deprived groups’ that defined their sample through 
individual level indicators (e.g. educational level, income) or area level indicators (e.g. 
postcode). 'Older adults’, defined as aged 50 years + (or when the majority of the sample was 
aged 40+) were included to represent a sample at or approaching lung cancer screening age 
(25). The review included studies that examined behavioural aspects of SCIs and outcomes 
including smoking abstinence and psychosocial variables such as quit motivation, nicotine 
dependence, perceived social influence and quit determination. 
Data extraction and synthesis 
Study outcomes, including moderating variables and selected study features were extracted. 
Where relevant, statistical associations between variables are described in order to examine 
relationships within and between the included studies. Data from qualitative elements of 
included studies were extracted and a narrative synthesis was conducted. Due to the 
heterogeneity of included studies, a narrative synthesis was performed using guidance 
outlined by Popay (26) and organised under relevant behavioural intervention elements. 
Critical Appraisal 
The methodological quality of included studies and risk of bias was assessed using an 
adapted Critical Appraisal Skills Programme (CASP) tool (27). Quality was assessed 
according to each domain on the checklist including rationale, study design, recruitment, 
sample size, data collection and analysis, ethical issues, reporting of findings and contribution 
to research. The CASP tool was adapted to address quality of methods for verifying smoking 
abstinence, intervention type, and socioeconomic and age variation within the sample. 
Overall quality was categorised as high, medium or low.  
Patient and Public Involvement 
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Patient and public involvement was not adopted for the review. 
RESULTS 
Eleven studies met the inclusion criteria (Figure 1). Nine of the 11 studies were quantitative 
(28-36) and two were mixed-methods design (37, 38). Three studies were randomised control 
trials, with the remaining using a range of non-randomised designs. Two studies (28, 34) 
were conducted in a lung screening context. Quality of included studies was high (n=2), 
medium (n=5) and low (n=4). Limitations of lower quality studies included measuring but 
not reporting a subgroup analysis of age and/or deprivation, study design, limited description 
of the intervention and statistically underpowered results.  Where available, relevant 
statistical values are presented in Table 2. 
Nine studies used a combination of nicotine replacement therapy and behavioural counselling 
(28-30, 32-37). One study used only nicotine replacement therapy (31) and one used 
behavioural counselling without nicotine replacement therapy (38). Results are presented in 
relation to intervention elements including the behavioural content, setting, intervention 
provider and mode and duration of delivery. A sub-heading under each intervention element 
presents data on smoking outcomes. Further study characteristics and findings are also 
presented in Table 2. 
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Table 2: Study Characteristic 
                                                          
1 Odds ratio 
2 Confidence interval 
3 Adjusted odds ratio 
Study (Country) Study design Sample Intervention Measure of 
smoking 
abstinence 
Summary of findings Quality 
appraisal 
Bade et al (2016) 
(Germany) 
Randomised 
controlled 
trial 
4052 participants from the German 
lung cancer screening intervention 
trial. 
1535 (62%) male, 950 (38%) female. 
1737 (70%) aged 50-59 years, 748 
(30%) 60-69 years old. 
ϭϴϮϯ ;ϳϯ%Ϳ ͚loǁ͛ in eduĐation and ϭϱϵϰ 
;ϲϱ%Ϳ ͚loǁ͛ in ǀoĐational training. 
Low-dose multislice CT 
screening and smoking 
cessation counselling (SCC) 
delivered by a psychologist in a 
radiology department. 20 
minute counselling followed by 
at least one telephone call. 
Self-report 
at 12 and 24 
months 
Proportion of current smokers decreased 
among screenees (3.4%, p<0.0001), controls 
(4.5%, p<0.0001), and entire cohort (4.0%, 
p<0.0001). The magnitude of decrease in 
smoking rate was larger in SSC participants 
(screenees 9.6%, p<0.0001; controls 10.4%, 
p<0.0001) compared to non-SSC participants 
(screenees 0.8%, p=0.30; controls 1.6%, 
p=0.03). 
High 
Bauld et al (2009) 
(United Kingdom) 
Observational 
study 
1785 pharmacy service users. 
762 (56%) in the Starting Fresh (SF) 
group and 311 (76%) in the Smoking 
Concerns (SC) group were aged 41 
years or older.  
796 (58%) from SF were in the lowest 
deprivation quintile, 187 (46%) from SC 
were in the lowest quintile. 
Behavioural support delivered 
by a trained adviser in a group-
based community setting (SC) 
up to 12 weeks or individually 
in a pharmacy setting (SF) up to 
12 weeks, with access to 
nicotine replacement therapy. 
Biochemical 
validation at 
1 month 
146 (36%) quit rate in SC versus 255 (19%) in SF 
(OR1=1.98; 95% CI2 1.90 to 3.08). SC and SF 
deprived smokers had lower cessation rates 
(OR=0.677; p=0.015). Cessation rate for 
pharmacy clients increased sharply with age 
from 13.4% for age 16–40 to 30.7% for age 61 
and over (p<0.001). The increase for group-
based clients (SC) was statistically insignificant 
(p<0.25).  Determination to quit was not 
statistically significant: P = 0.072 (SF) and P = 
0.092 (SC). 
Medium 
Celestin Jr et al 
(2016) 
(United States) 
Retrospective 
cohort study 
ϴ, ϱϰϵ toďaĐĐo users in Louisiana͛s 
public hospital facility. 
1531 (68%) in the intervention group 
were aged 45 years and over. 
1,196 (57%) were from the lowest 
͚finanĐial Đlass͛. 
 
Standard care plus group 
behavioural counselling in a 
hospital classroom. 4 one-hour 
sessions, once a week within a 
1-month period. 
 
Self-report 
at 12 
months 
Intervention participants had greater 
odds of sustained abstinence than non-
attendees (aOR3=1.52; 95% CI 1.21 to 1.90). 
Higher 12-month quit rate in patients over age 
60 (22%) compared to 18-30 year olds (11%) 
(aOR 2.36; 95% CI 1.58 to 3.52). There was a 
statistically significant effect of COPD status on 
quit rate (from UOR 1.01 CI 0.86 to 1.19, to 
AOR 0.75 CI 0.63 to 0.90). 
Low 
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Copeland et al 
(2005) 
(United Kingdom) 
 
Observational 
cohort study 
101 patients from a disadvantaged 
area of Edinburgh. Mean age for males 
was 47 years and for females was 44 
years.  
GP consultation and 
subsequent prescription of 
nicotine replacement therapy 
Self-report 
at 3 months 
 
Post intervention 35 (35%) smoked the same, 
46 (45%) were smoking less and 20 (20%) had 
stopped smoking. 
Older participants were more likely to have 
stopped or to be smoking less (p<0.00). 
Low 
Lasser et al (2017) 
(United States) 
Prospective, 
randomised 
trial 
352 participants randomised (177 
intervention, 175 control). 
197 (56%) aged 51-74. 
193 (55%) with a household yearly 
income <$20,000. 
Patient navigation and financial 
incentive (intervention) versus 
enhanced traditional care 
(control). Intervention received 
4 hours of support over 6 
months. Delivered by patient 
navigators over the phone or 
in-person. 
Biochemical 
validation at 
12 months 
21 (12%) intervention participants quit 
smoking compared to 4 (2%) control 
participants (OR=5.8, 95% CI 1.9 to 17.1, 
p<0.00). 
In the intervention arm (n=177), participants 
aged 51-74 had higher quit rates compared to 
those aged 21-50 (19 [19.8%] vs 2 [2.0%]; p< 
0.00). Household yearly income of <$20,000 
had higher quit rates compared to >$20,000 
(15 [15.5%] vs 4 [8%]; p= 0.00). 
Medium 
Neumann et al 
(2013) 
(Denmark) 
 
 
Observational 
prospective 
cohort study 
20,588 disadvantaged patients (low 
level of education and receiving 
unemployment benefits). 
15,244 (74%) aged 40 years or over. 
 
6-week manualised Gold 
Standard Programme in 
hospitals and primary care 
facilities (e.g. pharmacies). 
Delivered in 5 meetings over 6 
weeks by a certified staff 
member. Both group and 
individual counselling was 
offered. 
Self-
reported 
continuous 
abstinence 
at 6 months 
34% of responders reported 6 months of 
continuous abstinence. 
Continuous abstinence was significantly lower 
in those with less education (30%) versus more 
education (35%) (p<0.00). 
For participants with a lower educational level, 
individual counselling was a predictor of 
success in smoking cessation (OR=1.31, 95% CI 
1.05 to 1.63). 
Medium 
Ormston et al 
(2015)  
(United Kingdom) 
 
 
Mixed-
methods, 
quasi-
experimental 
study 
2042 smokers living in deprived areas 
of Dundee. 70 (54%) aged 45 years and 
over. 119 (92%) from the two most 
deprived areas. 
Financial incentive and 
behavioural support based on 
Scottish national guidelines, 
with pharmacotherapy (Quit4u 
Scheme) delivered in group 
(practice nurses) and one-to-
one settings (community 
pharmacists) for up to 12 
weeks. 
Biochemical 
validation at 
1, 3 and 12 
months 
Intervention was responsible for 36% of all quit 
attempts in the three most deprived areas. 12 
month quit rate (9.3%) was significantly higher 
than other Scottish stop smoking services 
(6.5%) (relative difference 1.443, 95% CI 1.132 
to 1.839, p=0.00). 
Medium 
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Park et al (2015) 
(United States) 
Matched case 
control study 
3336 National Lung Screening Trial 
participants. 
Aged 55 to 74 years old.  
No report of deprivation at baseline. 
Subgroup analysis performed for 
education.  
SCI delivered by a primary care 
clinician using the 5As. 
Self-report 
at 12 
months 
Assist was associated with a 40% increase in 
quitting (OR=1.40, 95% CI 1.21 to 1.63). 
Arrange was associated with a 46% increase in 
quitting (OR=1.46, 95% CI 1.19 to 1.79). Higher 
educational level was significantly associated 
with quitting after delivery of each of the 5As 
(ORs=1.14 to 1.26 for college degree or higher 
versus high school education). Lower nicotine 
dependence (OR= 0.94, 95% CI 0.91-0.98), and 
higher quit motivation (OR=1.28, 95% CI 1.21-
1.35) were significantly associated with 
quitting after delivery of each of the 5As 
Medium 
Sheffer et al (2013) 
(United States) 
Observational 
study 
7267 participants in telephone 
treatment: 30% aged >50 years, 35% 
aged 36-49 years.  
In-person participants: 38% aged >50 
years, 38% aged 36-49 years.   
No report of deprivation at baseline. 
Subgroup analysis performed for 
deprivation. 
Behavioural counselling- 
manual driven sessions 
delivered weekly in-person 
(healthcare settings) or over 
the telephone, with free 
nicotine patches for 6 weeks. 
Delivered by a health care 
provider trained in brief 
evidence-based tobacco 
dependence interventions. 
 
Self-report 
at 3 and 6 
months 
Abstinence rates were higher for in-person 
counselling (37.7%) versus telephone 
counselling (30.8%) (p<0.00). No significant 
difference at 3 months (p=0.73) and 6 months 
(p=0.27) between in-person (28.2%; 27.2%) 
and telephone (28.7%; 28.7%). The highest 
socioeconomic (SES) group was more likely to 
be abstinent with telephone treatment (SES3: 
P =0.03; OR = 1.45; 95% CI = 1.04, 2.01). No 
significant differences between the in-person 
and telephone for the two lower SES groups 
(SES1: OR=1.02, 95% CI 0.88 to 1.18, p=0.82; 
SES2: OR=0.91, 95% CI 0.72 to 1.15, p=0.41). 
Low 
Sheikhattari et al 
(2016) 
(United States) 
 
 
Randomised 
controlled 
trial 
409 (52%) were aged 48 years and 
over.  
Recruited in targeted communities 
where more than 40% of the 
households earn less than $25,000. 531 
(72%) were unemployed.  
Peer-led community-based 
intervention over three phases. 
Phase 1 (n=404) – the American 
Cancer 
SoĐiety͛s ϰ-week Fresh Start 
smoking cessation curriculum 
expanded to 12 weeks at 
health centres and delivered by 
a doctor, nurse or social 
worker. Phase 2 (n=398) and 
Phase 3 (n=163) – tailored 
group counselling in 
community venues, delivered 
by trained peer motivators. 
Self-report 
and 
biochemical 
validation at 
3 and 6 
months 
Delivery of services in community settings was 
a predictor of quitting (OR=2.6, 95% CI 1.7 to 
4.2). Smoking cessation increased from 38 
(9.4%) in Phase 1 to 84 (21.1%) in Phase 2, and 
49 (30.1%) in Phase 3. Phases 2 and 3 were 
associated with higher odds compared to 
Phase 1, with adjusted ORs of 2.1 (95% CI 1.3 
to 3.5) and 3.7 (95%CI 2.1 to 6.3) respectively. 
Older age (>48 years versus <48 years) was 
associated with higher quit rate (13.3% vs 
19.1%, p=0.028). 
High 
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Stewart et al (2010) 
(Canada) 
Pilot 
evaluation of 
a before and 
after study 
44 women, aged 25-69, living on low 
income in urban areas of Western 
Canada.  
23 (52%) aged 40 years or older.  
18 (39%) participants unemployed, 26 
(62%) on welfare/income support. 
Facilitated group support 
supplemented with one-to-one 
support from a mentor. Once a 
week, duration of 12 weeks 
minimum. Groups facilitated by 
professionals and former 
smokers with the option of 
one-to-one from peers in 
community centres.  
Self-report 
at 3 months 
The mean number of cigarettes smoked daily 
decreased from pre to post-test (p=0.00).  
Among women completing all data collection 
(n=22), the mean number of cigarettes 
consumed daily decreased from 0.95 pre-
intervention to 0.32 immediately after the 
intervention, then increased to 0.64 at 3 
months post-intervention. Four women 
reported sustained cessation. 
Low 
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Behavioural intervention content 
Ten studies focused on meeting the individual participant’s needs using education and 
motivational techniques including support and encouragement (28-30, 32-38). In all ten 
studies, the interventions involved used motivational techniques with varying levels of 
intensity (Table 2).  
Nine studies used interventions that were of higher intensity (28-30, 32, 33, 35-38). These 
studies involved incorporating specific action planning, tailored by the participant’s level of 
quit motivation (28), using a combination of manual-based teaching and patient education 
sessions including relapse prevention modules (36), motivational interviewing techniques 
(32), discussions on the benefits and costs of smoking versus cessation (33), empowering 
strategies to enhance self-efficacy (38) and cognitive behavioural content (35). 
Three studies used financial incentives as part of their intervention (32, 36, 37). A 
randomised control trial conducted by Lasser et al (32) offered participants $750 for 
abstinence at 12-month follow-up. This element of the intervention was combined with 
patient navigation in which trained navigators identified and discussed salient social 
contextual factors using motivational interviewing. Ormston et al (37) combined behavioural 
support with financial incentives to participants upon biochemically verified cessation.  
Outcomes 
A study by Park et al (34) found that the 'assist' and 'arrange follow-up' elements of a brief 
SCI based on the 5As (ask, advise, assess, assist and arrange follow-up) alongside lung 
cancer screening significantly increased the odds of quitting. Results showed that the 
decrease in smoking rate was larger for participants who received behavioural support 
compared to those who did not. Smoking abstinence was higher in participants with a higher 
educational level. (Table 2).   
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Studies of interventions that involved using financial incentives found that older participants 
and those with the lowest income had higher quit rates (Table 2). Ormston et al (37) found 
that quit rates for the intervention group were significantly higher compared to other stop 
smoking services (Table 2). Seventy-one percent of participants reported that the incentive 
component was ‘very’ or ‘quite useful’ in helping them quit, with participants describing it as 
a ‘bonus’ or ‘reward’ to motivate them.   
Stewart et al (38) reported qualitative data on self-efficacy for quitting and found that 
participants thought the education they gained from the intervention increased their 
awareness of their smoking habits, reasons why they smoked and the importance of quitting. 
Participants also reported an increase in the number of available support sources (e.g. parents, 
spouse and friends) along with a significant increase in perceived social support (38).   
Setting 
Two studies took place in a lung screening setting (28, 34) and used contrasting forms of 
interventions. Park et al (34) offered a brief SCI delivered by a primary care clinician, 
whereas Bade et al (28) used a more intensive intervention delivered by a psychologist who 
was trained in tobacco treatment. The latter study used a randomised control trial design with 
a large sample size and took place in the radiology department before or after the 
participant’s screening.  
Five studies were delivered in a variety of easily accessible community settings including 
community pharmacies (29, 33, 37) and community venues such as centres and churches (29, 
36-38) (Table 2). Three studies took place at medical facilities such as local medical/health 
centres (31, 32, 35) and two studies took place in hospitals (30, 33). One study delivered the 
intervention in both community and primary care settings (33). 
Outcomes 
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Stewart et al (38) used a community-based intervention that took place in a local community 
centre, familiar to participants. Findings from this small-scale pilot study of female smokers 
suggested that the number of cigarettes smoked decreased post-intervention (Table 2). 
Ormston et al (37) compared intervention delivery in community pharmacies and behavioural 
support (both group and one-to one sessions) to other stop smoking services and 
demonstrated significantly higher quit rates in deprived communities (Table 2). 
Bauld et al (29) showed that specialist-led group-based services have higher quit rates 
compared to one-to-one services that are provided by pharmacies. Cessation rates for 
pharmacy clients increased with age, and more deprived smokers had lower smoking 
cessation rates in both the pharmacy-led and one-to-one services (Table 2). Sheikhattari et al 
(36) found higher quit rates for community-based participants compared to those receiving 
support in clinics during phase 1 of the intervention (Table 2). Results from this study also 
showed that older age (defined as over 48 years) was associated with higher quit rates for 
participants.  
Provider 
Interventions were delivered by a range of providers (Table 2). Seven studies employed 
healthcare professionals such as general practitioners, primary care practice nurses, 
psychologists and pharmacists (28, 30, 31, 33-35, 38). Two studies employed trained peer 
motivators to deliver their intervention. Sheikhattari et al (36) used peer motivators who were 
former smokers to deliver the behavioural sessions. Peer motivators lived or worked in the 
community and were trained in delivering the intervention. Lasser et al (32) used patient 
navigators who had completed 10 hours of training in motivational interviewing techniques 
and had experience of working in community settings. 
Outcomes 
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Smoking abstinence outcomes varied according to SCI provider (Table 2). A small-scale 
observational study by Copeland et al (31) examined the use of nicotine replacement theory 
and a brief GP consultation. Results showed that older smokers were more likely to have 
stopped smoking (Table 2). 
Sheikhattari et al (36) demonstrated that subsequent phases of the intervention delivered by 
trained peer facilitators were associated with higher odds of quitting compared to the first 
phase where intervention delivery was conducted by a doctor, nurse or social worker (Table 
2). Findings from Lasser et al (32) demonstrated that older participants and those with a 
lower household yearly income had higher quit rates (Table 2).  
Qualitative data from Stewart et al (38) demonstrated that participants felt peer facilitators 
helped to support their cessation efforts as they were able to share personal experiences and 
strategies. Participants reported that they were able to learn coping strategies and techniques 
from other participants in the group which then helped them with their quit attempt.  
Mode and duration  
Studies varied in the mode and duration of delivery of SCIs (Table 2). Seven studies 
examined both individual and group behavioural counselling sessions (29, 30, 32, 33, 35, 37, 
38) (Table 2) and four studies used only one-to-one behavioural support (28, 31, 32, 34). 
Duration of interventions varied greatly between and within studies (Table 2). The shortest 
duration was an intervention embedded in a GP consultation (31) and the longest was 16 
weeks of smoking cessation support (38). 
Outcomes 
Bauld et al (29) showed that participants accessing group-based services were almost twice as 
likely as those who used individual pharmacy-based support to have quit smoking at four 
weeks (Table 2). Similarly, Celestin et al (30) showed that attendees of group behavioural 
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counselling had significantly higher long-term quit rates compared to non-attendees. 
Sheikhattari et al (36) used a six-week group-counselling module followed by a six-week 
relapse prevention module. Higher odds of quitting were associated with later phases of the 
intervention in which community-based group counselling was delivered (Table 2). 
Lasser et al (32) delivered their one-to-one behavioural support over six months either in-
person or over the telephone, with a goal of four hours per participant. Results demonstrated 
that more participants from the intervention group had quit smoking in comparison to the 
control group (Table 2). Bade et al (28) also employed behavioural counselling in-person, 
with at least one subsequent telephone call for those who had specified a quit date. 
Participants were offered four telephone calls that lasted around 20 minutes in duration and 
findings demonstrated a larger decrease in smoking for screening attendees compared to non-
attendees (Table 2).  
Sheffer et al  (35) delivered both telephone and in-person behavioural counselling. Smoking 
abstinence rates were higher for in-person counselling, with smokers from higher 
socioeconomic groups more likely to quit after telephone counselling than smokers from 
lower socioeconomic groups. Neumann et al (33) offered either group or individual 
counselling and demonstrated that for those with a lower educational level, individual 
counselling was a predictor of smoking cessation (Table 2). 
Moderating variables 
Seven studies reported limited data on moderating variables (28-30, 32, 34-36). Bauld et al 
(29) found that smokers who reported being ‘extremely determined’ to quit were more likely 
to be successful in their quit attempt. Celestin et al (30) demonstrated that COPD status had a 
statistically significant effect on quit rates (Table 2) and Park and colleagues (34) showed that 
lower nicotine dependence and higher quit motivation were significantly associated with 
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quitting after the delivery of each of the 5As. Three RCTs demonstrated that participants who 
had a lower Fagerstrom score (36), who were contemplating quitting (32) and reported high 
readiness to quit (28) at baseline were more likely to have abstained from smoking post-
intervention.  
DISCUSSION 
To our knowledge, this systematic review is the first to examine the influence of behavioural 
SCIs for an older, deprived population. The majority of included studies used a combination 
of pharmacotherapy and a form of behavioural counselling, supporting previous evidence that 
a combined approach is the most effective for older, deprived smokers (21). Additionally, 
findings relating to the intensity, provider, mode, duration and setting of behavioural 
counselling are encouraging. Behavioural counselling delivered in a community setting and 
tailored to individual needs appeared to demonstrate a positive impact on smoking cessation 
outcomes. 
Behavioural interventions identified in the current review used a range of approaches and 
although none of the included studies explicitly described their intervention as "tailored", 
many used a form of behavioural counselling that was implicitly flexible according to the 
needs of the individuals. Interventions were implemented in locations that addressed barriers 
to access, such as local community centres, and intervention content was driven by the 
individual’s psychological needs (29, 36-38). Previous research suggests that in order for 
people to access stop smoking services, the appointments should be flexible and accessible 
(39).  
The optimal mode and duration of intervention was unclear from our review, with findings 
suggesting varying success for both group and one-to-one behavioural support. The current 
results reflect similar findings from a review conducted in the UK. Bauld et al (21) concluded 
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that due to a dearth of studies examining subpopulations of smokers, further research is 
needed to determine the most effective models of treatment for smoking cessation and their 
efficacy with these subgroups (21). The current review did, however, demonstrate that certain 
aspects of behavioural interventions, such as incentives, the use of peer facilitators and more 
intensive counselling are promising for encouraging cessation in older, deprived smokers. 
Additionally, limited data regarding the influence of moderating variables suggests that 
factors such as nicotine dependence, quit motivation and pre-existing health conditions such 
as COPD can impact the effectiveness of smoking cessation interventions. Future research 
should aim to understand the needs and preferences of older, deprived smokers and focus on 
psychosocial mechanisms that can be targeted in more holistic level interventions. 
The eleven studies included in the review were heterogeneous in design, SCI modality, 
sample size, intervention timing and measurement of smoking abstinence. Some of the 
included studies did not report confidence intervals, thus making it difficult to interpret 
findings. Only three of the studies included were randomised control trials, of which one was 
underpowered (32), thus the effectiveness results across the studies were modest. Chen and 
Wu (40) also identified the need for controlled trials of SCIs for older smoker, in order to 
better understand the most suitable form of intervention for this population. Similarly to 
findings from Pineiro et al’s systematic review (41), the studies in the current review did not 
consistently use biochemical verification of smoking cessation, with most relying on self-
reported smoking cessation (Table 2).  
Various design aspects of the included studies, including the use of non-randomised methods, 
limited the extent to which firm conclusions can be drawn about the effectiveness of 
behavioural SCIs for older, deprived smokers. Only two studies included qualitative process 
evaluation data, limiting the ability to understand why specific intervention characteristics 
were more or less likely to influence smoking cessation outcomes. Evidence suggests that 
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smokers from disadvantaged backgrounds face particular obstacles to successful quitting such 
as lack of support, higher nicotine dependence and life stress (20). Further mixed-methods 
research is therefore warranted to understand why some forms of SCI support may be more 
suited to mitigating these barriers in the target population.  
The findings indicate a clear lack of evidence from large-scale trials of effectiveness in a lung 
screening context as well as a lack of data reporting psychosocial moderators of cessation for 
older, deprived smokers. We acknowledge methodological limitations of the present 
systematic review. By restricting the inclusion criteria for age and socioeconomic group, 
several potentially relevant studies were excluded. For example, telephone-based counselling 
for smokers undergoing lung cancer screening, involving messages about risks of smoking in 
the context of lung scan results, can improve self-efficacy for quitting and the likelihood of a 
successful quit attempt (42). However, our review highlights the current absence of robust 
evidence regarding behavioural SCIs that are effective for the lung screening eligible 
population of older deprived smokers. 
CONCLUSION 
Our systematic review demonstrates the potential for tailored, multimodal SCIs for older, 
deprived smokers that can be embedded within disadvantaged communities. With the 
prospect of lung cancer screening being implemented in the UK and Europe in the near 
future, this research adds to the evidence base regarding promising SCIs for older, deprived 
populations who will benefit most from lung screening and integrated smoking cessation 
support.  Further studies to understand the psychosocial barriers to quitting in the target 
population should be conducted to inform the design and conduct of high-quality trials of 
intervention effectiveness in older, deprived smokers. 
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FIGURE LEGEND 
Figure 1: PRISMA Flow Diagram 
